Mast cell activation syndrome in COVID‐19 and female reproductive function: theoretical background vs. accumulating clinical evidence

D Szukiewicz, P Wojdasiewicz… - Journal of …, 2022 - Wiley Online Library
Coronavirus disease 2019 (COVID‐19), a pandemic disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, can affect almost all systems …

[HTML][HTML] Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome

LB Afrin, LB Weinstock, GJ Molderings - International journal of infectious …, 2020 - Elsevier
Abstract Objectives One-fifth of Covid-19 patients suffer a severe course of Covid-19
infection; however, the specific causes remain unclear. Mast cells (MCs) are activated by …

[HTML][HTML] Mast cell activation symptoms are prevalent in Long-COVID

LB Weinstock, JB Brook, AS Walters, A Goris… - International Journal of …, 2021 - Elsevier
Objectives Hyper-inflammation caused by COVID-19 may be mediated by mast cell
activation (MCA) which has also been hypothesized to cause Long-COVID (LC) symptoms …

What immunological and hormonal protective factors lower the risk of COVID-19 related deaths in pregnant women?

Y Berhan - Journal of Reproductive Immunology, 2020 - Elsevier
Despite anticipated increased risk of COVID-19 and increased expression of the SARS CoV-
2 receptor (ACE2), the relatively low mortality of pregnant women with COVID-19 has been …

Mast cell activation syndrome and the link with long COVID

S Arun, A Storan, B Myers - British Journal of Hospital …, 2022 - magonlinelibrary.com
Mast cells are innate immune cells found in connective tissues throughout the body, most
prevalent at tissue-environment interfaces. They possess multiple cell-surface receptors …

Immunological dysfunction and mast cell activation syndrome in long COVID

S Sumantri, I Rengganis - Asia Pacific Allergy, 2023 - journals.lww.com
At least 65 million people around the world suffer from long COVID-19, with the majority of
cases occurring in the productive age (36–50 years old). Individuals with long COVID-19 are …

Female reproductive health during the COVID-19 pandemic: latest evidence and understanding

S Li, H Liu, D Li, F Chen - Archives of Gynecology and Obstetrics, 2023 - Springer
Purpose The ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has imposed a heavy burden on …

Connecting the dots in emerging mast cell research: do factors affecting mast cell activation provide a missing link between adverse COVID-19 outcomes and the …

R da Silveira Gorman, IU Syed - Medical Sciences, 2022 - mdpi.com
Evidence continues to emerge that the social determinants of health play a role in adverse
outcomes related to COVID-19, including increased morbidity and mortality, increased risk of …

Mast cell's role in cytokine release syndrome and related manifestations of COVID-19 disease

Ö Özdemir, AY Göksu Erol… - Current Pharmaceutical …, 2022 - ingentaconnect.com
In this narrative review, firstly, we describe the characteristics of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and the pathogenesis of its infection in humans …

The influence of COVID-19 infection-associated immune response on the female reproductive system

M Saadedine, M El Sabeh, MA Borahay… - Biology of …, 2023 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) is a multi-system disease that has led to a
pandemic with unprecedented ramifications. The pandemic has challenged scientists for the …